GENESYS
GENESYS
Each stock's 10,000-path forecast, rendered as light.
GENESYS (GENESYS) Stock Analysis & Case Study
Is GENESYS a good buy? The data-driven verdict.
GENESYS (GENESYS) trades at ₹358,on the numbers it high-risk on the numbers, a Downstox Snapshot Score of 14/100.
On the numbers, GENESYS (GENESYS) high-risk on the numbers, a Downstox Snapshot Score of 14/100, weighing expensive at 41.2× earnings, ROE of 5.7%, a 23% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
GENESYS fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
Is GENESYS overvalued? GENESYS P/E vs its sector
GENESYS's P/E of 41.2× sits above the sector peer median of 15.9×, so on earnings it screens richer than peers.
GENESYS share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.0y of GENESYS history (-28%/yr drift, 61%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| GENESYS 2027 | ₹101 | ₹220 | ₹482 | -37% |
| GENESYS 2028 | ₹45 | ₹138 | ₹419 | -61% |
| GENESYS 2029 | ₹22 | ₹88 | ₹338 | -75% |
| GENESYS 2030 | ₹11 | ₹54 | ₹259 | -85% |
| GENESYS 2031 | ₹6 | ₹35 | ₹197 | -90% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability GENESYS goes up, or doubles?
The bull case for GENESYS
- GENESYS is part of the nifty500 universe with live, tracked fundamentals on Downstox.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹338.
The bear case & risks
- A rich 41.2× P/E leaves a thin margin of safety if growth slows.
- Return on equity is a soft 5.7%, capital efficiency trails higher-quality peers.
- A low Piotroski F-Score of 3/9 flags weaker financial health this cycle, worth understanding why before committing.
- The probability model is cautious 12 months out, only a 23% chance of finishing above today's price.
- High historical volatility (61%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹22.
GENESYS volatility & expected range, how bumpy is the ride?
Over the last 2.0 years GENESYS compounded at -28%/year with annualized volatility of 61%. That volatility implies a 1-year 80% range of ₹101–₹482, the honest backbone behind any single price target.
GENESYS price forecast, the full 60-month probability fan
GENESYS price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds GENESYS hits common targets within the simulated horizon?
Full multi-horizon detail on the GENESYS price target & forecast page.
GENESYS Piotroski F-Score: 3/9, how financially strong is it?
The Piotroski F-Score grades financial strength on nine profitability, leverage and efficiency checks. GENESYS scores 3/9,weak on the financial-strength checks.
GENESYS MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy GENESYS with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| ZerodhaCHEAPEST | 46.6% | 2.1× |
| Dhan | 64.0% | 1.6× |
Compare every broker on the GENESYS MTF page.
GENESYS vs peers,sector comparison
About GENESYS: sector, index & market-cap context
GENESYS (GENESYS) is a small-cap NSE-listed company, and a constituent of the Nifty 500 index group, with a market capitalisation of ₹1,490 Cr. See more Nifty 500 stocks.
How the GENESYS Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of GENESYS's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
GENESYS analysis, FAQs
Is GENESYS (GENESYS) a good buy?
On the numbers, GENESYS (GENESYS) high-risk on the numbers, a Downstox Snapshot Score of 14/100, weighing expensive at 41.2× earnings, ROE of 5.7%, a 23% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is GENESYS overvalued or undervalued?
GENESYS trades at 41.2× earnings versus a peer median of 15.9×, so it screens richer than its sector peers.
What is the GENESYS share price target for 2031?
GENESYS's probability-weighted 2031 median target is ₹35, with an 80% range of ₹6–₹197 (10,000-path Monte-Carlo).
What is the probability GENESYS doubles in 5 years?
The modelled probability of GENESYS reaching ₹702 (2×) within 5 years is 1%.
What is the bull case for GENESYS?
GENESYS is part of the nifty500 universe with live, tracked fundamentals on Downstox.
What are the risks in GENESYS?
A rich 41.2× P/E leaves a thin margin of safety if growth slows. Return on equity is a soft 5.7%, capital efficiency trails higher-quality peers. A low Piotroski F-Score of 3/9 flags weaker financial health this cycle, worth understanding why before committing.